Pharmacodynamic and Pharmacokinetic Profiles of Prasugrel in Patients With ST Elevation Myocardial Infarction: A Randomized Comparison of Standard Versus Crushed Formulation

Trial Profile

Pharmacodynamic and Pharmacokinetic Profiles of Prasugrel in Patients With ST Elevation Myocardial Infarction: A Randomized Comparison of Standard Versus Crushed Formulation

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Dec 2016

At a glance

  • Drugs Prasugrel (Primary) ; Prasugrel (Primary)
  • Indications Myocardial infarction
  • Focus Pharmacodynamics
  • Most Recent Events

    • 18 Mar 2016 Primary endpoint has been met. (Platelet reactivity unit), as per results published in the Journal of the American College of Cardiology.
    • 18 Mar 2016 Results published in the Journal of the American College of Cardiology
    • 01 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top